Cite
gyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-guided Therapy
MLA
Murray, Gl, et al. GyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1397540694&authtype=sso&custid=ns315887.
APA
Murray, G., Plummer, E., Bodiyabadu, K., Vodstrcil, L., Huaman, J., Danielewski, J., Chua, T., Machalek, D., Garland, S., Doyle, M., Sweeney, E., Whiley, D., & Bradshaw, C. (2023). gyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-guided Therapy.
Chicago
Murray, Gl, El Plummer, K Bodiyabadu, La Vodstrcil, Jl Huaman, Ja Danielewski, Tp Chua, et al. 2023. “GyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1397540694&authtype=sso&custid=ns315887.